Standout Papers

Nadroparin for the prevention of thromboembolic events in ambulatory patients... 2005 2026 2012 2019 500
  1. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study (2009)
    Giancarlo Agnelli, Gualberto Gussoni et al. The Lancet Oncology
  2. A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery (2005)
    Giancarlo Agnelli, Giorgio Bolis et al. Annals of Surgery

Immediate Impact

92 standout
Sub-graph 1 of 20

Citing Papers

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
2023 Standout
Cancer-associated venous thromboembolism
2022 Standout
39 intermediate papers

Works of C. Bianchini being referenced

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
2009 Standout
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
2005 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
C. Bianchini 747 951 18 415 30 1.4k
Murray M. Bern 349 467 13 443 60 1.5k
A Alastrué 265 525 4 427 32 1.3k
Marcello De Cicco 175 460 15 524 37 1.6k
Sean Dolan 583 769 16 245 36 1.6k
D W Barritt 783 884 18 114 38 1.6k
Luke Bamber 830 639 6 117 27 1.1k
J. Zahavi 470 292 16 61 36 1.1k
M Samama 529 644 2 81 56 1.4k
Meyer‐Michel Samama 832 1007 4 85 59 1.5k
Fred J.L.M. Haas 306 381 11 120 46 1.1k

All Works

Loading papers...

Rankless by CCL
2026